S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Asian shares mostly rise after House approves debt ceiling deal
Bank Collapse Causes Gold Prices to Soar (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Bank Collapse Causes Gold Prices to Soar (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Asian shares mostly rise after House approves debt ceiling deal
Bank Collapse Causes Gold Prices to Soar (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Bank Collapse Causes Gold Prices to Soar (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Asian shares mostly rise after House approves debt ceiling deal
Bank Collapse Causes Gold Prices to Soar (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Bank Collapse Causes Gold Prices to Soar (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Asian shares mostly rise after House approves debt ceiling deal
Bank Collapse Causes Gold Prices to Soar (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Bank Collapse Causes Gold Prices to Soar (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
NASDAQ:TPST

Tempest Therapeutics (TPST) News Today

$1.53
-0.09 (-5.56%)
(As of 05/31/2023 ET)
Compare
Today's Range
$1.53
$1.69
50-Day Range
$1.36
$3.76
52-Week Range
$1.06
$4.21
Volume
59,901 shs
Average Volume
161,031 shs
Market Capitalization
$17.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
Get Tempest Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TPST and its competitors with MarketBeat's FREE daily newsletter.



TPST Media Mentions By Week

TPST Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TPST
News Sentiment

0.15

0.78

Average
Medical
News Sentiment

TPST News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TPST Articles
This Week

5

1

TPST Articles
Average Week

SourceHeadline
finance.yahoo.com logoTempest to Present at the Jefferies Global Healthcare Conference
finance.yahoo.com - May 31 at 8:26 PM
markets.businessinsider.com logoAnalyst Ratings for Tempest Therapeutics
markets.businessinsider.com - May 30 at 7:42 PM
finance.yahoo.com logoTempest to Present Phase 1 Monotherapy and Combination Data at ASCO for TPST-1495 in Patients with Advanced Cancers
finance.yahoo.com - May 25 at 7:44 PM
finance.yahoo.com logoTempest to Present Phase 1 Monotherapy and Combination Data at ASCO for TPST-1495 in Patients with Advanced Cancers
finance.yahoo.com - May 25 at 7:44 PM
finance.yahoo.com logoTempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - May 19 at 5:59 PM
MarketBeat logoTempest Therapeutics, Inc. Forecasted to Earn Q2 2023 Earnings of ($0.64) Per Share (NASDAQ:TPST)
americanbankingnews.com - May 17 at 1:36 AM
MarketBeat logoTempest Therapeutics, Inc. to Post Q2 2023 Earnings of ($0.52) Per Share, William Blair Forecasts (NASDAQ:TPST)
americanbankingnews.com - May 16 at 1:28 AM
msn.com logoHC Wainwright & Co. Reiterates Tempest Therapeutics (TPST) Buy Recommendation
msn.com - May 12 at 10:20 AM
finanznachrichten.de logoTempest Therapeutics: Tempest Reports First Quarter 2023 Financial Results and Provides Business Update
finanznachrichten.de - May 11 at 2:58 PM
markets.businessinsider.com logoAnalysts Have Conflicting Sentiments on These Healthcare Companies: Tempest Therapeutics (TPST), MannKind (MNKD) and Alkermes (ALKS)
markets.businessinsider.com - May 11 at 9:57 AM
finance.yahoo.com logoTempest Reports First Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - May 10 at 6:48 PM
finance.yahoo.com logoTempest Reports First Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - May 10 at 6:48 PM
msn.com logoTempest Therapeutics, Inc. (TPST) Upgraded to Buy: What Does It Mean for the Stock?
msn.com - May 1 at 2:38 PM
MarketBeat logoTempest Therapeutics (NASDAQ:TPST) Price Target Raised to $14.00
americanbankingnews.com - May 1 at 1:52 AM
marketwatch.com logo8-K: Tempest Therapeutics, Inc.
marketwatch.com - April 29 at 10:37 AM
msn.com logoLadenburg Thalmann Maintains Tempest Therapeutics (TPST) Buy Recommendation
msn.com - April 29 at 10:37 AM
MarketBeat logoShort Interest in Tempest Therapeutics, Inc. (NASDAQ:TPST) Declines By 29.9%
americanbankingnews.com - April 29 at 8:08 AM
markets.businessinsider.com logoTempest Announces Positive Results From Phase 1b/2 Trial Of TPST-1120 In Hepatocellular Cancer
markets.businessinsider.com - April 28 at 1:52 PM
msn.com logoTempest Soars after Positive Clinical Data for TPST-1120
msn.com - April 28 at 1:52 PM
msn.com logoTempest surges ~40% as TPST-1120 shows promise in liver cancer trial
msn.com - April 28 at 1:52 PM
finance.yahoo.com logoTempest Announces Positive Early Results from Global Randomized Phase 1b/2 Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
finance.yahoo.com - April 28 at 8:51 AM
finance.yahoo.com logoTempest to Report Early Results from Global Randomized Phase 1b/2 Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
finance.yahoo.com - April 27 at 6:51 PM
benzinga.com logoTempest Announces TPST-1495 Poster Presentation at the 2023 ASCO Annual Meeting
benzinga.com - April 26 at 8:02 PM
finance.yahoo.com logoTempest Announces TPST-1495 Poster Presentation at the 2023 ASCO Annual Meeting
finance.yahoo.com - April 26 at 8:02 PM
finance.yahoo.com logoTempest Announces New Translational and Preclinical Data Presented at the 2023 AACR Annual Meeting
finance.yahoo.com - April 17 at 10:07 AM
MarketBeat logoTempest Therapeutics, Inc. (NASDAQ:TPST) Short Interest Update
americanbankingnews.com - March 31 at 7:26 AM
benzinga.com logoTempest Therapeutics Stock (NASDAQ:TPST), Dividends
benzinga.com - March 30 at 2:09 PM
MarketBeat logoTempest Therapeutics, Inc. Forecasted to Earn Q2 2023 Earnings of ($0.71) Per Share (NASDAQ:TPST)
americanbankingnews.com - March 28 at 1:38 AM
MarketBeat logoTempest Therapeutics (NASDAQ:TPST) Given New $6.00 Price Target at Piper Sandler
americanbankingnews.com - March 26 at 4:24 AM
bbc.co.uk logoShakespeare’s The Tempest plot summary
bbc.co.uk - March 24 at 9:53 AM
MarketBeat logoEquities Analysts Offer Predictions for Tempest Therapeutics, Inc.'s Q1 2023 Earnings (NASDAQ:TPST)
americanbankingnews.com - March 24 at 6:18 AM
MarketBeat logoHC Wainwright Reiterates Buy Rating for Tempest Therapeutics (NASDAQ:TPST)
americanbankingnews.com - March 24 at 5:32 AM
finanznachrichten.de logoTempest Therapeutics: Tempest Reports Year End 2022 Financial Results and Provides Business Update
finanznachrichten.de - March 23 at 7:28 AM
finance.yahoo.com logoTempest Reports Year End 2022 Financial Results and Provides Business Update
finance.yahoo.com - March 22 at 10:36 PM
finance.yahoo.com logoTempest Reports Year End 2022 Financial Results and Provides Business Update
finance.yahoo.com - March 22 at 5:35 PM
finance.yahoo.com logoTempest to Present Biomarker Data for TPST-1120 at the Society for Immunotherapy of Cancer (SITC) 2023 Spring Scientific Meeting
finance.yahoo.com - March 15 at 6:44 PM
finance.yahoo.com logoTempest to Present Biomarker Data for TPST-1120 at the Society for Immunotherapy of Cancer (SITC) 2023 Spring Scientific Meeting
finance.yahoo.com - March 15 at 6:44 PM
finance.yahoo.com logoTempest to Present New Translational and Preclinical Data at the 2023 AACR Annual Meeting
finance.yahoo.com - March 14 at 9:36 PM
bbc.co.uk logoKS2 Music: The Tempest
bbc.co.uk - February 18 at 6:07 PM
finance.yahoo.com logoBears are Losing Control Over Tempest Therapeutics, Inc. (TPST), Here's Why It's a 'Buy' Now
finance.yahoo.com - December 5 at 6:34 PM
finance.yahoo.com logoTempest to Present at the Piper Sandler 34th Annual Healthcare Conference
finance.yahoo.com - November 22 at 6:24 PM
finance.yahoo.com logoTempest Presents Data Showing TPST-1120-Induced Pharmacodynamic Changes Consistent with Clinical Benefit Observed in Patients with Cancer
finance.yahoo.com - November 10 at 3:47 PM
finance.yahoo.com logoTempest Reports Third Quarter 2022 Financial Results and Provides Business Update
finance.yahoo.com - November 8 at 8:56 AM
finance.yahoo.com logoTempest Announces Data Presentations, including a Late-Breaking Presentation on TPST-1120, at the SITC Annual Meeting
finance.yahoo.com - November 2 at 1:11 PM
msn.com logo6KMPH, DDI : Benzinga's Top Ratings Upgrades, Downgrades For...
msn.com - September 15 at 11:34 AM
finance.yahoo.com logoTempest to Present at the H.C. Wainwright 24th Annual Global Investment Conference
finance.yahoo.com - September 7 at 10:10 AM
finance.yahoo.com logoTempest to Present at the H.C. Wainwright 24th Annual Global Investment Conference
finance.yahoo.com - September 7 at 10:10 AM
seekingalpha.com logoTempest Therapeutics GAAP EPS of -$0.79
seekingalpha.com - August 17 at 8:21 PM
investing.com logoTempest Therapeutics, Inc. Tops Q2 EPS by 13c
investing.com - August 17 at 12:19 AM
finance.yahoo.com logoTempest Reports Second Quarter 2022 Financial Results and Provides Business Update
finance.yahoo.com - August 15 at 8:22 AM
Get Tempest Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TPST and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TPST) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -